Evidence map›Paper›PMID 36298851›Full record

ArticleViruses2022

Evolutionary Pattern Comparisons of the SARS-CoV-2 Delta Variant in Countries/Regions with High and Low Vaccine Coverage.

Jiahao Zhang, Linqian Fan, Hanli Xu, Yuanhui Fu, Xianglei Peng, Yanpeng Zheng, Jiemei Yu, Jinsheng He

Abstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiahao ZhangCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Linqian FanCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Hanli XuCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Yuanhui FuCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Xianglei PengCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Yanpeng ZhengCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.
Jiemei YuCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.ORCID 0000-0003-2988-384X
Jinsheng HeCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.ORCID 0000-0002-6592-0540

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been argued that vaccine-breakthrough infections of SARS-CoV-2 would likely accelerate the emergence of novel variants with immune evasion. This study explored the evolutionary patterns of the Delta variant in countries/regions with relatively high and low vaccine coverage based on large-scale sequences. Our results showed that (i) the sequences were grouped into two clusters (L and R); the R cluster was dominant, its proportion increased over time and was higher in the high-vaccine-coverage areas; (ii) genetic diversities in the countries/regions with low vaccine coverage were higher than those in the ones with high vaccine coverage; (iii) unique mutations and co-mutations were detected in different countries/regions; in particular, common co-mutations were exhibited in highly occurring frequencies in the areas with high vaccine coverage and presented in increasing frequencies over time in the areas with low vaccine coverage; (iv) five sites on the S protein were under strong positive selection in different countries/regions, with three in non-C to U sites (I95T, G142D and T950N), and the occurring frequencies of I95T in high vaccine coverage areas were higher, while G142D and T950N were potentially immune-pressure-selected sites; and (v) mutation at the N

Indexed as

COVID-19SARS-CoV-2COVID-19 VaccinesHumansMutationSpike Glycoprotein, CoronavirusCOVID-19 VaccinesSpike Glycoprotein, Coronavirusco-mutationgenetic divergenceimmune pressuremethylationSARS-CoV-2vaccine coverage

Identifiers

PMID36298851
PMCPMC9611485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.